Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

ClinicalTrials.gov ID: NCT00315887

Public ClinicalTrials.gov record NCT00315887. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind Comparative Study of Buprenorphine Transdermal System (BTDS) and Hydrocodone/Acetaminophen Tablets in Patients With Chronic Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to assess the safety and efficacy of the buprenorphine transdermal system (5, 10, and 20 mg) in comparison to placebo transdermal system and hydrocodone/acetaminophen in subjects with chronic back pain. The double-blind treatment intervention duration is 56 days during which time supplemental analgesic medication (ibuprofen) will be provided to all subjects in addition to study drug.

Study identification

NCT ID
NCT00315887
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
250 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1999 (Type not available)
Primary completion
Not listed
Completion
Oct 1999 (Type not available)
Last update posted
May 3, 2006

1999

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Rheumatology Associates of North Alabama Huntsville Alabama 35801 —
Arizona Research Center Phoenix Arizona 85023 —
Arthritis Center of Connecticut Waterbury Connecticut 06708 —
University Clinical Research DeLand Florida 32720 —
Gainesville Clinical Research Center Gainesville Florida 32605 —
Miami Research Associates Miami Florida 33173 —
Sarasota Arthritis Center Sarasota Florida 34239 —
Coastal Medical Research South Daytona Beach Florida 32119 —
Palm Beach Research Center West Palm Beach Florida 33409 —
Private Practice Weston Florida 33331 —
Pain Management & Rehabilitation Terre Haute Indiana 47807 —
Mid-America Rheumatology Consultants Overland Park Kansas 66209 —
Riverhills Healthcare Crestview Hills Kentucky 41017 —
Arthritis & Osteoporosis Treatment & Research Center Jackson Mississippi 39216 —
Center for Pharmaceutical Research Kansas City Missouri 64114 —
PrecisionMed, Inc. Las Vegas Nevada 89128 —
Cornerstone Research Care High Point North Carolina 27262 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
Center for Clinical Research Austin Texas 78758 —
The Arthritis Clinic of Northern Virginia Arlington Virginia 22206 —
Evergreen Clinical Research Edmonds Washington 98026 —
Private Practice Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00315887, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2006 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00315887 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →